Moreover, the activation of BARs, including FXR, TGR5, VDR in monocytes/macrophages cells, DCs, NKT cells, ILC, Th17, and Treg cells, exerts anti-inflammatory and immunomodulatory effects, which may partially explain the positive effects of probiotics on IBD. This evidence concerns the gene GPBAR1 and inflammatory bowel disease.